Electronic Dashboard and Strategies to Improve Outcomes in Pediatric Patients with Type 2 Diabetes Mellitus
Main Article Content
Abstract
Background: In the last decade, the prevalence of Type 2 Diabetes Mellitus (T2DM) has dramatically increased in children and adolescents. This population is at increased risk of long-term complications compared to those diagnosed in adulthood.
Methods: A comprehensive program was developed to help manage our patients with T2DM. The healthcare team is comprised of multiple members and utilizes both manual and electronic tools, including a PowerBI electronic dashboard with data integration to the Electronic Medical Record (EMR), to optimize care. Goals included reducing hemoglobin A1c (A1c), increasing communication, and decreasing frequency of missed visits. A quality nurse was assigned to monitor this disease state, and, because of the capacities of the technology, she was able to monitor population health in this disease state, and 5 others, at the same time.
Results: The percentage of newly diagnosed patients who achieved an A1c less than 8.0% within 6 months improved from 42% to 80%. Outpatient follow-up 10 weeks after diagnosis increased from 57% to 72%. After implementation of an electronic dashboard, our total patient population with A1c of less than 8% improved from 55% to 59%, and total missed appointments decreased from 40% to 23%.
Conclusions: Manual tracking and utilization of an electronic dashboard resulted in significant improvement of care in our patients with Type 2 diabetes. Electronic dashboards provide a low-cost and efficient way to better understand clinic demographics and track improvements for a specific patient population. Efforts should focus on increasing communication and continuity of care for pediatric patients with Type 2 diabetes, given its increasing prevalence and impact on patient wellbeing and the healthcare system.
Highlights
- Implementation of an electronic dashboard significantly improved glycemic control in pediatric patients with Type 2 Diabetes Mellitus (T2DM).
- Newly diagnosed patients achieving A1c < 8% within 6 months increased from 42% to 80%.
- Missed follow-up appointments for established patients decreased from 40% to 23% after dashboard implementation.
- The dashboard enabled real-time tracking, automated outreach, and enhanced patient engagement through telehealth and incentives.
Manual tracking and structured follow-up programs were particularly effective for newly diagnosed patients.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Xu, H., & Verre, M. C. (2018). Type 2 diabetes mellitus in children. American Family Physician, 98(9), 590–594.
3. Haines, L., Wan, K. C., Lynn, R., Barrett, T. G., & Shield, J. P. H. (2007). Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care, 30(5), 1097–1101. https://doi.org/10.2337/dc06-1813
4. Narasimhan, S., & Weinstock, R. S. (2014). Youth-onset type 2 diabetes mellitus: Lessons learned from the TODAY study. *Mayo Clinic Proceedings, 89*(6), 806–816. https://doi.org/10.1016/j.mayocp.2014.01.009
5. Fotea, S., Ghiciuc, C. M., Stefanescu, G., Cianga, A. L., Mihai, C. M., Lupu, A., Butnariu, L. I., Starcea, I. M., Salaru, D. L., Mocanu, A., Chisnoiu, T., Thet, A. A., Miron, L., & Lupu, V. V. (2023). Pediatric COVID-19 and diabetes: An investigation into the intersection of two pandemics. *Diagnostics, 13*(14), 2436. https://doi.org/10.3390/diagnostics13142436
6. Sandblom, L., Kapadia, C., Vaidya, V., Chambers, M., Gonsalves, R., Holzmeister, L. A., Hoekstra, F., & Goldman, S. (2024). Electronic dashboard to improve outcomes in pediatric patients with type 1 diabetes mellitus. *Journal of Diabetes Science and Technology, 18*(5), 1102–1108. https://doi.org/10.1177/19322968231159401
7. Buonalumi Tacito Yugar, L., Sedenho-Prado, L. G., Castilho da Silva Ferreira, I. M., Moreira Silva, C. A., Sposito, A. C., & Cercato, C. (2024). The efficacy and safety of GLP-1 receptor agonists in youth with type 2 diabetes: A meta-analysis. Diabetology & Metabolic Syndrome, 16, Article 92. https://doi.org/10.1186/s13098-024-01337-5
8. Huang, A., Roberts, A., Mohsenian, Y., & Kim, G. (2025). Improving prescribing rates of glucagon-like peptide 1 receptor agonists in youth with type 2 diabetes. Clinical Diabetes, 43(3), 429–434. https://doi.org/10.2337/cd24-0070
9. Klinkhammer, A. (2023). The efficacy of GLP-1 agonists in pediatric patients with type 2 diabetes: A literature review. University of North Dakota Physician Assistant Scholarly Project Papers, 200. https://commons.und.edu/pas-grad-papers/200/